Pamidronate Disodium for Injection

This product is a bisphosphonate drug. In vitro and animal tests have shown that it can strongly inhibit the dissolution of hydroxyapatite and the activity of osteoclasts, and has a very significant inhibitory effect on bone absorption. It has an analgesic effect on pain caused by osteolytic bone metastasis of cancer, and can also be used to treat hypercalcemia caused by cancer.

The chemical name is: 3-amino-1-hydroxypropylidene-1,1-diphosphonic acid disodium pentahydrate.

Hypercalcemia complicated by malignancy and bone pain caused by osteolytic cancer metastasis.

Treatment of bone metastasis pain: dilute in 0.9% saline or 5% glucose solution without calcium ions before use. Slow intravenous drip for more than 4 hours, the concentration should not exceed 15mg/125ml, and the drip rate should not be greater than 15-30mg/2 hours. 30-60mg per dose. Treatment of hypercalcemia: medication should be used strictly according to blood calcium concentration and under the guidance of a doctor.

A small number of patients may experience mild nausea, chest pain, chest tightness, dizziness, fatigue, and slight changes in liver and kidney function, and occasionally fever.

1. Patients with a history of allergy to this product and bisphosphonate preparations are prohibited from using this product. 2. Children are prohibited from using this product. 3. Pregnant and lactating women should use this product with caution.

Precautions for children: Children are prohibited. Precautions for pregnancy and lactation: Pregnant and lactating women should use with caution.

Not yet clear.

Keep away from light, tightly closed, in a cool place.

15mg

EMeiShan Tonghui Pharmaceutical Co., Ltd.

• Founded in:

  2002-03-29

• Address:

  Tonghui Road, Processing, Warehousing and Logistics Park, Emeishan City

• Tax NO.:

  91511181621167487U

• Registered Funds:

  54.138461 yuan

• Website:

  Log in to view

• Email:

  Log in to view